Skip to main content
Figure 4 | Radiation Oncology

Figure 4

From: In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

Figure 4

Presents In vivo tumor growth of rhabdomyosarcoma (RMS) xenografts after treatment with 3 × 3Gy fractionated radiation or XRT and SAHA for 3 weeks (Cohort II). Local failure was defined as a tumor growth > 1000 mm3. Local Control was calculated according to the method of Kaplan and Meier. Fifty days after treatment start.

Back to article page